• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND VITALITY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND VITALITY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number T180
Device Problems Over-Sensing (1438); Pacing Problem (1439); Low impedance (2285); Device Sensing Problem (2917)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/21/2014
Event Type  malfunction  
Event Description
Boston scientific received information that this implantable defibrillator and right ventricular (rv) lead exhibited low shocking lead impedance measurements less than 20 ohms on a day the patient was having surgery.Noise on both rv and shock channel was also noted a month before the said procedure.Additional information was received and indicated that the cause was not determined.Noise was oversensed and led to pacing inhibition.However, no inappropriate therapy or greater than two seconds asystole had been observed.No intervention was performed.The patient would continue to be monitored.No adverse patient effects were reported.
 
Manufacturer Narrative
(b)(4).As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the device was performed.A visual inspection of the device header and case noted body fluid contamination in the lead barrels and a hole in the right atrial seal plug.Analysis noted that no shocks were delivered after the painless shock impedance measured less than 20 ohms.Analysis review of the device¿s memory found the device did shock into an open lead condition.No noise was noted during testing.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.
 
Event Description
The implantable cardioverter defibrillator (icd) was explanted over a year later for reported normal battery depletion and was returned for analysis four months after explant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITALITY
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
sonali vasekar
4100 hamline ave. n
st. paul, MN 55112
6515824786
MDR Report Key4149204
MDR Text Key4929187
Report Number2124215-2014-14888
Device Sequence Number1
Product Code KRG
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative,company representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/07/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/13/2008
Device Model NumberT180
Other Device ID NumberVITALITY DR HE
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/10/2015
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 07/17/2014
Initial Date FDA Received10/07/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/26/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/14/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
1861; T180; 4469; 1853
Patient Age72 YR
-
-